Impact of the COVID-19 pandemic on oncological and functional robotic-assisted surgical procedures.
Thomas BlancUgo PinarJulien AnractJalal AssouadFrançois AudenetBruno BorgheseAlexandre De La TailleAlaa El GhoneimiPierre Mongiat-ArtusPierre MordantChristophe PennaMorgan RoupretPublished in: Journal of robotic surgery (2021)
The COVID-19 pandemic led to a decrease in surgical activity to avoid nosocomial contamination. Robotic-assisted surgery safety is uncertain, since viral dissemination could be facilitated by gas environment. We assessed the impact and safety of the COVID-19 pandemic on robotic-assisted surgery. Data were collected prospectively during lockdown (March 16th-April 30th 2020) in 10 academic centres with robotic surgical activity and was compared to a reference period of similar length. After surgery, patients with suspected COVID-19 were tested by RT-PCR. During the COVID-19 lockdown we evidenced a 60% decrease in activity and a 49% decrease in oncological procedures. However, the overall proportion of oncological surgeries was significantly higher during the pandemic (p < 0.001). Thirteen (7.2%) patients had suspected COVID-19 contamination, but only three (1.6%) were confirmed by RT-PCR. The COVID-19 pandemic resulted in a significant decrease in robotic-assisted surgery. Robotic approach was safe with a low rate of postoperative COVID-19 contamination.
Keyphrases
- sars cov
- coronavirus disease
- minimally invasive
- robot assisted
- coronary artery bypass
- risk assessment
- respiratory syndrome coronavirus
- drinking water
- rectal cancer
- end stage renal disease
- surgical site infection
- radical prostatectomy
- health risk
- prostate cancer
- chronic kidney disease
- patients undergoing
- ejection fraction
- pulmonary embolism
- escherichia coli
- machine learning
- electronic health record
- deep learning
- methicillin resistant staphylococcus aureus
- acinetobacter baumannii
- room temperature
- staphylococcus aureus
- artificial intelligence